The European e-Business Report The European e ... - empirica
The European e-Business Report The European e ... - empirica
The European e-Business Report The European e ... - empirica
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>The</strong> <strong>European</strong> E-<strong>Business</strong> <strong>Report</strong> 2005<br />
2.4 <strong>The</strong> Pharmaceutical Industry<br />
<strong>The</strong> e-<strong>Business</strong> W@tch sector<br />
study on the Pharmaceutical<br />
Industry was contributed by<br />
Berlecon Research GmbH (contact:<br />
info@berlecon.de).<br />
<strong>The</strong> full reports (parts 1 and 2) can<br />
be downloaded from the website<br />
(www.ebusiness-watch.org) at the<br />
'resources' section.<br />
<strong>The</strong> pharmaceutical industry is well suited to the use of ICT and e-business applications. This is true<br />
for both internal processes and for the support of B2B relationships. As a result, the industry is an<br />
intensive user of e-business. ICT and internet-based solutions also play an increasingly important role<br />
in supporting marketing and sales processes. CRM (customer relation management) systems and<br />
mobile solutions have a high potential for facilitating the management and work of the pharmaceutical<br />
sales force. Combating counterfeiting activities could be a driver for the deployment of RFID/Auto-ID<br />
solutions in this sector in the future.<br />
2.4.1 Sector definition and background<br />
Sector definition<br />
Activities subsumed under NACE 62 24.4 constitute the core of the pharmaceutical industry. <strong>The</strong><br />
reports, however, also cover the activities of the cosmetics industry (NACE 24.51) and the<br />
manufacture of soaps and detergents, cleaning and polishing preparations (NACE 24.52). <strong>The</strong> latter<br />
two sub-sectors have several things in common with the core pharmaceutical industry, which justifies<br />
their joint consideration.<br />
Exhibit 2.4-1: <strong>Business</strong> activities covered by the pharmaceutical industry (NACE Rev. 1.1)<br />
NACE Rev. 1.1<br />
DE 24.4<br />
DE 24.5<br />
<strong>Business</strong> Activity<br />
Manufacture of pharmaceuticals, medicinal chemicals and botanical products<br />
Manufacture of soap and detergents, cleaning and polishing preparations, perfumes and<br />
toilet preparations.<br />
In contrast to most other parts of the chemical sector, subsumed under NACE 24 (manufacture of<br />
chemicals, chemical products and man-made fibres), the outputs of the pharmaceutical industry are<br />
mostly produced for end-users and not for other firms of the chemical industry. In addition, most of<br />
these products can have an immediate impact on human health. <strong>The</strong>refore, the industry has to meet<br />
high safety standards and is subject to many regulatory measures in order to ensure the consumers’<br />
safety.<br />
Finally, companies active in the sub-sectors analysed by e-<strong>Business</strong> W@tch often use similar<br />
distribution channels such as pharmacies and drugstores. For the sector studies, therefore, the term<br />
“pharmaceutical industry”, is intended to include the whole sector as defined above.<br />
62<br />
NACE revised version 1.1 – final draft 2002. See glossary for explanation.<br />
95